Table 1.
Metabolite | Category † | Day 2 | Day 6 | ||
---|---|---|---|---|---|
Fold Change | Fold Change | ||||
1 Gy/0 Gy | 3 Gy/0 Gy | 1 Gy/0 Gy | 3 Gy/0 Gy | ||
Increased (38 metabolites) | |||||
2-Aminobutyric acid | 1.58 * | 1.7 * | 1.27 * | 1.45 * | |
3-Phosphoglyceric acid | Sugar metabolism | 1.33 | 1.71 * | 1.05 | 0.74 |
5-Oxohexanoic acid | 1.48 * | 1.21 | 1.37 * | 1.22 | |
ADP-glucose | Nucleotide sugars, Nucleotide sugars, Vascular | 1.22 | 1.42 * | 1.08 | 1.07 |
GDP-fucose | |||||
ADP-ribose | 0.48 | 0.87 | 1.1 | 1.83 * | |
Alanine | Cytokine, Hormone, Hemocyte, Renal disease, Uremic toxin, Sugar metabolism | 1.04 | 1.06 | 1.12 | 1.3 * |
ATP | Purine bases, Sugar metabolism | 1.22 | 1.46 * | 1.09 | 0.81 |
Cumic acid | N.D. | N.D. | 1.4 * | 1.1 | |
Decanoic acid | Lipid, Fatty Acid metabolism | 1.25 | 1.01 | 1.38 * | 1.06 |
Flavin mononucleotide | 1.62 | 2.08 * | 1.29 * | 0.78 | |
Glutamine | Hemocyte | 0.99 | 1.15 * | 1.05 | 1 |
Glutathione (GSH) | Anti-oxidant, Lipid Fatty Acid metabolism, Methylglyoxal | 0.83 | 1.67 * | 0.92 | 0.95 |
GTP | Purine bases | 1.38 | 1.76 * | 1.24 | 0.81 |
Heptanoic acid | Lipid, Fatty Acid metabolism | 1.51 | 1 | 1.4 * | 1.17 |
Hexanoic acid | Lipid, Fatty Acid metabolism | 1.33 | 1.06 | 1.21 * | 1.02 |
Histidine | 1.06 | 1.18 * | 1.01 | 1.02 | |
Isoleucine | Essential amino acid, Lipid, Fatty Acid metabolism, Liver disease, Sugar metabolism | 1.03 | 1.27 * | 1.12 | 1.01 |
Isobutyric acid | Apoptosis, Carcinogenesis, Cell function, Lipid, Fatty Acid metabolism | 1.67 * | 1.11 | 1.08 | 1.12 |
Butyric acid | |||||
Isovaleric acid | Lipid, Fatty Acid metabolism | 1.57 * | 1.16 | 1.19 | 1 |
Valeric acid | |||||
Leucine | Essential amino acid, Insulin, Lipid, Fatty Acid metabolism, Liver disease, Protein metabolism | 1.11 | 1.33 * | 1.17 | 1.19 * |
Malonylcarnitine | 1.02 | 1.16 | 1.31 * | 0.85 | |
Octanoic acid | Lipid, Fatty Acid metabolism | 1.02 | 0.94 | 1.15 * | 0.98 |
Octanoylcarnitine | 0.53 | 0.81 | 1.31 * | N.D. | |
Ophthalmic acid | 1.11 | 1.16 | 1.15 | 1.34 * | |
p-Toluic acid | 1.7 * | 1.12 | N.D. | N.D. | |
m-Toluic acid | |||||
o-Toluic acid | |||||
Pelargonic acid | Lipid, Fatty Acid metabolism | 1.33 | 1.04 | 1.22 * | 0.99 |
Phenylalanine | Catecholamines and Derivatives, Essential amino acid | 1.04 | 1.17 * | 1.06 | 0.92 |
Phosphoenolpyruvic acid | Sugar metabolism | 1.45 | 1.9 * | 1.13 | 0.75 |
S-Methylcysteine | Anti-oxidant, Sugar metabolism | 0.97 | 1.17 * | N.D. | N.D. |
Sedoheptulose 7-phosphate | 1.44 | 1.24 | 1.19 | 1.63* | |
Thiaproline | 1.13 | 1.52 * | 1.15 | 1.09 | |
Tyramine | Catecholamines and Derivatives, Nervous system | N.D. | N.D. | 1.47 * | 1.17 |
UDP-N-acetylgalactosamine-1 | 1.22 * | 1.27 * | 1.09 | 0.93 | |
UDP-N-acetylglucosamine-1 | |||||
Undecanoic acid | Lipid, Fatty Acid metabolism | N.D. | N.D. | 1.56 * | 1.09 |
Valine | Essential amino acid, Liver disease, Nervous system, Sugar metabolism | 1.06 | 1.25 * | 1.06 | 1.02 |
XA0002 (unknown peak) | 0.93 | 0.97 | 0.92 | 1.16 * | |
XC0132 (unknown peak) | 1.13 | 1.26 * | N.D. | N.D. | |
γ-Glutamyl-cysteine | 1.03 | 2.06 * | 0.83 | 0.87 | |
Decreased (61 metabolites) | |||||
2-Hydroxy-4-methylvaleric acid | Maple syrup urine disease | 0.63 * | 0.6 * | 0.78 | 0.8 |
2’-Deoxycytidine | Pyrimidine bases | 0.57 * | 0.74 * | 0.73 * | 0.46 * |
3-Indoxylsulfuric acid | Renal disease, Uremic toxin, Vascular | 0.76 | 0.51 * | 0.61 | 0.78 |
5’-Deoxy-5’-methylthioadenosine | Purine bases | 0.84 | 0.55 * | 0.9 | 0.89 |
7,8-Dihydrobiopterin | Vascular | 0.41 * | 0.39 * | 0.99 | 0.3 * |
Acetoacetamide | 0.8 | 0.65 * | N.D. | N.D. | |
Adenine | Purine bases, Salvage pathway, Purine bases, Salvage pathway | 1.32 | 1.09 | 0.91 | 0.71 * |
Arginine | Guanidino compounds | 0.94 | 0.9 | 1.02 | 0.84 * |
Aspartic acid | Nervous system, Neuropsychiatric disorder, Sugar metabolism | 0.63 * | 0.57 * | 1.16 | 0.5 * |
Betaine | Osmolytes, Renal disease, Uremic toxin, Transmethyration | 0.79 * | 0.76 * | 1.11 | 0.83 |
Betonicine | 0.71 * | 0.69 * | 0.86 | N.D. | |
Butyrylcarnitine | 0.73 | 0.63 * | 0.75 | 0.93 | |
Carnitine | Lipid, Fatty Acid metabolism, Liver disease, Cardiac disease | 0.74 * | 0.72 * | 1.02 | 0.55 * |
Choline | Lipid, Fatty Acid metabolism, Transmethyration | 0.64 * | 0.64 * | 0.77 * | 0.38 * |
Citrulline | 0.87 | 0.8 * | 1.04 | 0.92 * | |
CMP-N-acetylneuraminate | Nucleotide sugars | 0.45 * | 0.44 * | 1.01 | 0.95 |
Creatine | Cell function | 0.89 | 0.9 * | 1.01 | 1.03 |
Creatinine | Protein metabolism, Renal disease, Uremic toxin, | 0.92 | 0.9 | 0.95 | 0.85 * |
Ectoine | 0.98 | 0.61 * | 0.84 | 0.67 | |
Ergothioneine | Anti-oxidant, Oxidative stress | 0.98 | 1.03 | 0.95 | 0.69 * |
Ethanolamine | 0.79 * | 0.89 | 1.08 | 0.59 | |
Fructose 1,6-diphosphate | Sugar metabolism | 0.75 | 0.92 | 0.87 | 0.4 * |
γ-Aminobutyric acid | Nervous system, Sugar metabolism | 0.73 * | 0.69 * | 0.67 | 0.45 |
Glycine | 0.84 * | 0.92 | 1.13 | 0.85 | |
Glycyl-aspartic acid | 0.46 * | 0.41 * | 1.3 | 0.36 * | |
Glycerol 3-phosphate | Sugar metabolism | 0.62 * | 0.69 * | 1.05 | 0.91 |
Hippuric acid | 0.98 | 0.57 * | 0.63 | 1.2 | |
Homocitrulline | 0.84 | 0.65 * | 0.76 * | 0.79 | |
Homovanillic acid | Catecholamines and Derivatives, Dopamine related substances, Nervous system | 0.74 * | 0.7 * | 0.95 | 0.6 |
Imidazolelactic acid | 0.64 * | 0.85 | 0.85 | 0.71 | |
Isethionic acid | 0.63 * | 0.63 * | 0.87 | 0.87 | |
Methionine sulfoxide | Oxidative stress | 0.9 | 0.67 * | 0.95 | 1.13 |
N-Acetylaspartic acid | N-Acetylated compounds, Nervous system | 0.82 * | 0.86 | 1.03 | 0.67 * |
N-Acetylgalactosamine | Sugar metabolism | 0.91 | 0.99 | 1.08 | 0.69 * |
N-Acetylmannosamine | |||||
N-Acetylglucosamine | |||||
N-Carbamoylaspartic acid | 0.32 * | 0.35 * | 0.74 | N.D. | |
N-Methylproline | 0.94 | 0.77 * | 0.73 | 0.53 | |
N,N-Dimethylglycine | Methylated compounds, Oxidative stress, Transmethyration | 0.96 | 0.87 | 0.9 | 0.8 * |
N6-Acetyllysine | Apoptosis, Cell function, DNA damage, N-Acetylated compounds | 0.74 * | 0.55 * | 0.78 | 0.75 * |
N6-Methyllysine | Methylated compounds, Transmethyration | 0.97 | 1.02 | 0.95 | 0.78 * |
O-Acetylcarnitine | Lipid, Fatty Acid metabolism, Nervous system | 0.89 | 0.94 | 0.85 * | 0.61 * |
Phosphorylcholine | Liver disease | 0.4 * | 0.32 * | 0.82 | 0.34 * |
Pipecolic acid | Liver disease | 0.81 * | 0.77 * | 0.86 | 0.75 |
Pyruvic acid | Ketosis, Lipid, Fatty Acid metabolism, Protein metabolism, Sugar metabolism | 0.72 * | 0.91 | 1.19 | 0.96 |
Ribulose 5-phosphate | 0.58 * | 0.69 | 0.89 | 0.75 | |
S-Adenosylmethionine | Liver disease, Neuropsychiatric disorder, Oxidative stress, Transmethyration | 0.94 | 1 | 0.94 | 0.87 * |
S-Lactoylglutathione | Methylglyoxal | 0.58 * | 0.76 | 0.68 | 0.57 |
Symmetric dimethylarginine | Methylated compounds, Protein metabolism, Renal disease, Uremic toxin, Transmethyration, Vascular | 0.91 | 1 | 1.05 | 0.6 * |
Spermidine | Polyamines | 0.3 * | 0.41 * | 1.18 | 0.11 * |
Stachydrine | Osmolytes, Renal disease, Uremic toxin, Transmethyration | 0.73 * | 0.61 * | 0.98 | 0.83 |
Thymidine | Pyrimidine bases | 0.56 * | 0.77 * | 0.88 | 0.43 * |
Trigonelline | 0.83 * | 0.62 * | 0.88 | 0.96 | |
Trimethylamine N-oxide | Osmolytes, Renal disease, Uremic toxin | 0.69 | 0.55 * | 1.52 | 1.36 |
Tyrosine | Catecholamines and Derivatives | 0.71 * | 0.79 | 0.97 | 0.65 * |
Urea | Protein metabolism | 0.81 * | 0.77 * | 0.85 | 0.78 |
XA0013 (unknown peak) | 0.65 | 0.42 * | N.D. | N.D. | |
XA0033 (unknown peak) | 0.45 * | 0.39 * | N.D. | N.D. | |
XA0055 (unknown peak) | 0.73 | 0.91 | 0.79 | 0.43 * | |
XC0040 (unknown peak) | 0.77 * | 0.78 * | 0.83 | 0.68 * | |
XC0061 (unknown peak) | 0.59 * | 0.57 * | 1.16 | 0.41 * | |
β-Alanine | 0.93 | 0.79 | 1.05 | 0.57 * | |
γ-Butyrobetaine | 0.76 * | 0.78 * | 0.78 | 0.36* | |
Increased and decreased (one metabolite) | |||||
Argininosuccinic acid | Renal disease, Uremic toxin | 0.75 * | 0.77 * | 1.25 * | 0.58 * |
* Comparative analysis was performed by one-way ANOVA and post hoc Dunnett’s test. A p-value of less than 0.05 was considered statistically significant. † Metabolite categories were derived from the Kyoto Encyclopedia of Genes and Genomes (KEGG) and the Human Metabolome Database (HMDB).